Skip to content

Blog

Antique Broking bullish on Indian pharma market for FY24, stays negative on US generics 

Antique Broking bullish on Indian pharma market for FY24, stays negative on US generics 

The brokerage firm sees domestic branded formulations-focused firms#39; growth rate in the mid-teen range, driven by a high single-digit increase in prices  Read More ​ The brokerage firm sees domestic branded formulations-focused firms#39; growth rate in the mid-teen range, driven by… Read More »Antique Broking bullish on Indian pharma market for FY24, stays negative on US generics 

en_USEnglish